bioRxiv / medRxivopen access
Efficacy and safety of masitinib in amyotrophic lateral sclerosis patients prior to loss of functionality: A subgroup analysis optimizing the benefit-risk profile of masitinib
neurology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 29760
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.